Category Archives: Ali’s Diabetes Course

INSULIN HOMEOSTASIS FOR HEALTHFUL AGING

MAJID ALI, M.D.

Free Access Library of Articles for Reversing Hyperinsulinism and Type 2 Diabetes

Townsend Insuliv Case Studies


References 
1.     M. Respiratory-to-Fermentative (RTF) Shift in ATP Production in Chronic Energy Deficit Disorders. Townsend Letter for Doctors and Patients. 2004;253:64-65.
2.     Ali M. Oxygen and Aging. Book Ali M. Oxygen and Aging. (Ist ed.) New York, Canary 21 Press. Aging Healthfully Book 2000. .
3.     Ali M. Succinate Retention. In: Chouchani ET, Victoria R. Pell VR, Edoardo Gaude E, et. al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431–435.
4.     Ali M. Succinate Retention: The Core Krebs Dysfunction in Immune-Inflammatory Disorders. Townsend Letter. 2015;388:84-85.
5.     Ali M. Epidemic of Dysoxygenosis and the Metabolic Syndrome. In: The Principles and Practice of Integrative Medicine. Volume 5. Pp 246-256. Canary 21 Press. New York. 2005.
6.     Ali M. Dysox and Climatic Chaos –  The primacy of oxygen issues over carbon issues. Part I. Townsend Letter-The examiner of Alternative Medicine. 2008;299:125-132.
7.     Ali M. Oxygen, Insulin Toxicity, Inflammation, And  the Clinical Benefits of Chelation. Part I. Townsend Letter-The examiner of Alternative Medicine. 2009;315:105-109. October, 2009.
8.     Ali M. Insulin Reduction and EDTA Chelation: Two Potent and Complementary Approaches For Preventing and Reversing Coronary Disease. Oxygen, Insulin Toxicity, Inflammation, and the  Clinical Benefits of Chelation – Part II. Townsend Letter-The examiner of Alternative Medicine. 2010;323:74-79. June 2010.
9.     Ali M. Dysox Model of Diabetes and De-Diabetization Potential. Townsend Letter-The examiner of Alternative Medicine. 2007; 286:137-145.
10. Ali M. Plan for Reversing Diabetes. New York, Canary 21 Press. Aging Healthfully Book 2011.
11. Ali M. Importance of Subtyping Diabetes Type 2 Into Diabetes Type 2A and Diabetes Type 2B. Townsend Letter-The Examiner of Alternative Medicine. 2014; 369:56-58.
12. Ali M. Dasoju S, Karim N, Amin J, Chaudary D. Study of Responses to Carbohydrates and Non-carbohydrate Challenges In Insulin-Based Care of Metabolic Disorders.  Townsend Letter-The Examiner of Alternative Medicine. 2016; 391:48-51.
13. Ali M, Fayemi AO, Ali O. Dasoju S, et al. Shifting Focus From Glycemic Status to Insulin Homeostasis. .  Townsend Letter-The Examiner of Alternative Medicine. 2017;402:91-96.
14. Itoh Y, Kawamata Y, Harada M, et al. Free fatty acids regulate insulin secretion from pancreatic Description: eta cells through GPR40Nature;422:173–176.
15. Kahn SE, 1, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444, 840-846.
16. Reaven GM, Hollenbeck C, Jeng CY, et al. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDMDiabetes. 1988;371020–1024.
17. Sako, Y. & Grill, V. E. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidationEndocrinology 127, 1580–1589 (1990). |
18. Rhodes, C. J. Type 2 diabetes — a matter of Description: eta-cell life and death? Science. 2005;307:380–384.
19. Kahn, S. E., Bergman, R. N., Schwartz, M. W., Taborsky, G. J. & Porte, D. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humansAm. J. Physiol.1992;262:E518–E523.
20. Ali  M. Molecular Basis of Autism and Dysuatonomia – The Impeded Progenitor Cell Progression (IPCP) model of ASD and Dysautonomia.  Townsend Letter for Doctors and Patients. 2017 (In press)
21. Ali  M.  Insulin Laboratory Ranges. https://alidiabetes.org/2016/02/25/insulin-laboratory-ranges/
22. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116 :1793B1801.
23. Shulman G. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease. N Engl J Med. 2014; 371:1131‑1141.
24. International Diabetes Federation. Diabetes Atlas. 2016. Seventh edition. www.diabetesatlas.org.
25. Kahn SE, 1, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444, 840-846.
26. Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very-Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiologic Changes in Responders and Nonresponders. Diabetes Care. 2016 Mar 21. pii: dc151942.
27. Tilman D, Clark M. Global diets link environmental sustainability and human health. Nature. 2014;515, 518B522.
28. Hu, F. B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011; 34:1249B1257.
29. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116 :1793B1801.
30. Shulman G. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease. N Engl J Med. 2014; 371:1131‑1141.
31. International Diabetes Federation. Diabetes Atlas. 2016. Seventh edition. www.diabetesatlas.org.
32. Kahn SE, 1, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444, 840-846.
33. Ali M. The Principles and Practice of Integrative Medicine Volume X: Darwin, Oxygen Homeostasis, and  Oxystatic Therapies.  3 rd. Edi. (2009) New York. Institute of Integrative Medicine Press.
34. Ali M. The Principles and Practice of Integrative Medicine Volume  XI: Darwin, Dysox, and Disease. 2000. 3rd. Edi. 2008. New York.  (2009) Institute of Integrative Medicine Press.
35. Ali M. The Principles and Practice of Integrative Medicine Volume  XII: Darwin, Dysox, and Integrative Protocols. New York (2009). Institute of Integrative Medicine Press.
36. Ali M. Oxygen, Inflammation, and Castor-Cise Liver Detox. Hormones. Townsend Letter-The examiner of Alternative Medicine. 2007. Published online. http://www.townsendletter.com/Dec2007/oxygen1207.htm
37. Ali  M. Philosophy and Science of holism in healing. APPNA Journal. 2015.
38. Ali M. Hyperinsulinism Associated With Breast and Prostate Cancer. Townsend Letter-The Examiner of Alternative Medicine. 2017;402:91-96.
39. Kamada N, Seo S-U, Zhiming C, et al. Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews Immunology. 2013;12:321-335.
40. Grocott M, Richardson A, Montgomery H, et a. Caudwell Xtreme Everest: a field study of human adaptation to hypoxia. Critical care 2007;11:151.
41. Bahi-Buisson N, Roze E, Dionisi C, et al. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol. 2008;50:945-9.
42. Stanley SA, Kelly L, Kaasmashri N, et al. Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism. Nature. 2016  531:647–650.
43. Murphy KG, Bloom SR. Gut hormones and the regulation of energy bhomeostasis. Nature. 2006;444:854-859.

 

Link to Am Important Article

Shifting Focus From Glycemic Status to Insulin Homeostasis for Stemming Global Tides of Hyperinsulinism and Type 2 Diabetes

by
Majid Ali, MD, FRCS (Eng), FACP; Alfred O. Fayemi, MD, MSc (Path), FCAP; Omar Ali, MD, FACC; Sabitha Dasoju, MB, BS; Daawar Chaudhary; Sophia Hameedi; Jai Amin; Kadin Ali; Benjamin Svoboda

http://www.townsendletter.com/Jan2017/insulin0117.html

 


Hyperinsulinism Associated With Breast and Prostate Cancer

Majid Ali, M.D.

Published in the Journal Townsend Letter (2017;409:66-69

(August 2017)


 

Hyperinsulinism fans the fire of cancer. In this article, I present case studies to show diet and integrative therapies can restore insulin homeostasis and, thereby:

  1. Reduce the risk of prostate and breast cancer growth.
  2. Improve results in the treatments of these cancer.

Two Dimensions of Insulin Dysregulation

 

An Essay Competition Article
By
Aliza Durrani
Age 13
Cherry Hill, New Jersey
7/19/17

 

In the article written by Doctor Majid Ali I have learned that Type 1 diabetes can’t get reversed while Type 2 can. This happens because Type 1 DM produces none to very little insulin while type 2  DM produces either a lot of insulin which does not work due to resistance or produce little to none insulin because their pancreas is failing after not being treated. In the article I agree with the author when he says we should be checking insulin level early on. In routine practice I am shocked that we don’t check insulin level and we only check glucose level. As a 13 year old that is a no brainer to me. If we check insulin level early on we can reverse the type 2 diabetes and since we only check glucose level this can cause people to go years to decades without being treated, resulting by the pancreas to burn out.


Insulin Diet, Insulin Detox, and Insulin Dysox

In the article I have learned that the glucose and insulin levels should be going down at the 2 hour mark in someone’s body who is not diabetic, but in the table the information is reported for a 75 year old women and it shows the glucose level and insulin level escalating each hour and not going down at the 2-3 hour mark, which means the person is diabetic and is insulin resistant. After the patient had completed a successful 3D protocol including diet, detox,and dysoxic comorbidities the last test taken on the graph was April 14, 2015 the test results appear to be normal because the levels were controlled and went down at the 2-3 hour mark resulting to her diabetes to be reversed. Also I have gained knowledge about Hyperinsulinism, it causes inflammation to organs, which can cause cancer, strokes,heart attack, etc. Hyperinsulinism is the pancreatic response to increased energy requirement to repair the injured tissue.


Two Dimensions of Insulin Dysregulation

Lastly I have learned that insulin dysregulation has two dimensions the first one is pathophysiology of hyperinsulinism(predates Type 2 DM and is not accompanied by glycemic),and the last one is dimension of T2D(accompanied by hyperglycemia). This article has given me a lot of knowledge and gives me a new look into the medical field. Studies like this will help the future to find cures for other medical issues.

What Might APPNA Contribute to Controlling Diabetes pandemic?

Majid Ali, M.D.

FRCS (Eng), FACP (Path)

Soul Author of The Principles and Practice of Integrative Medicine (12 Volumes) 


 

The author is available for personal communication concerning this paper with interested APPNA clinicians by phone at 212-873-2444 or by e-mail at askipm@aol.com.


The author’s work in molecular biology of oxygen1-6and molecular biology of insulin7-12 led him to recognize a need for a shift of focus from glycemic status to insulin homeostasis (the “Shift”).13,14 Here he marshals strong basic science and epidemiological lines of evidence for the Shift (Tables 1-3), and  presents robust reasons for suggesting that  APPNA,  a dedicated physician community, consider a long-term organizational  initiative to contribute efforts to stem global tides of hyperinsulinism which predates Type 2 diabetes (T2D) by five,  ten, or more years.

During the years of hyperinsulinism-to-T2D progression, cellular populations in nearly all body organs suffer diffuse and incremental damage inflicted by undetected and unmanaged non-metabolic toxicity of insulin dysregulation. Notable among them are disorders of neurodevelopment (autism and dysautonomia15,16), blindness from insulin-induced optic neuritis,13 mitochondrial dysfunction,1,13 immune-inflammatory entities,13 endothelial dysfunction,17 vagus nerve dysfunction,18 persistent cellular repair response (after chemotherapy for cancer,19 for instance), and hepatic lesions (such as steatosis). In his broader oxygen-insulin perspective of hyperinsulinism8 the author recognizes hyperinsulinism as chronic energetic response to increased energy requirements of cellular repair processes.

It is noteworthy that all clinical and laboratory work done for the above-cited publications was completed without any private or government funding. The same held for author’s related works in molecular and cellular pathology, as well as in therapeutics in the fields of environmental medicine, clinical nutrition, and immune-inflammatory disorders in the holistic-integrative models presented in the 10th, 11th, and 12thvolumes of The Principles and Practice of Integrative Medicine.20-22

Insulin Homeostasis Protocol

The central goal of the proposed “Insulin Homeostasis Protocol” (the “Protocol”) is for APPNA to develop and implement a long-term organizational plan for shifting focus from glycemic status to insulin homeostasis in order to: (1) improve clinical outcome of individual patients with integrative treatments: (2) simplify patient education for superior compliance; (3) build an organizational insulin database for ongoing studies of the non-metabolic and metabolic consequences of disrupted insulin homeostasis; (4) document the prevalence and patterns of progression of hyperinsulinism co-morbidities, including T2D; (5) gather clinical data for examining the efficacy of indigenous therapies; and (6) foster the science and philosophy of holism in healing.

The Protocol is designed to be an all-voluntary distance-learning (internet-based) program. No need for significant outside funding is anticipated for APPNA participating clinicians; the initial time commitment of the APPNA administrative staff is expected to be modest.

Notable Strengths of the Protocol

The Protocol has some especial strength.   Notable among them are: (1) enhanced clinical results for individual patients (extensively documented in the author’s Darwin and Dysox Trilogy20-22 and multiple case studies presented in this article); (2) no-cost internet-based distance learning for participating APPNA clinicians; (3) no clinical restrictions on the participants in the integrative model  of the dietary, detox, and lifestyle Protocol guidelines; (4) no restrictions on concurrent use of pharmacologic regimens; (5) simplicity and uniformity of record keeping format for the insulin database for publications (illustrated in Tables used for presenting ; (6) no need for contractual obligations for APPNA, nor for APPNA clinicians; and (7) no additional uncovered cost of initial post-glucose challenge insulin and glucose profiles, and limited follow-up yearly insulin tests  (as has been the case for the author and his colleagues).

Type 2 diabetes is a spreading pandemic. In 2013, China in a large national study reported a prevalence rate of prediabetes and Type 2 diabetes (T2D) (50.1% of adults).1 In 2017, the author and his colleagues reported a prevalence rate of hyperinsulinism of 75.1% in  a survey of post-glucose challenge insulin and glucose profiles in 684 subjects in New York metropolitan area.13 This, to the authors’ knowledge, was the first statistical documentation of hyperinsulinism-to-T2D progression with direct measurements of blood insulin and glucose concentrations with multiple timed blood samples following a 75-gram glucose challenge.  The much higher rate of hyperinsulinism (75.1%) in New York population than the prevalence of prediabetes and T2D among the Chinese (50.1%) is not surprising since tests for the glycemic status provide only indirect information concerning the underlying insulin dysregulation.

In the 201713 and earlier reports,7-12 the author and his colleagues explored the following questions: (1) How does insulin resistance begin; (2) What is optimal insulin homeostasis; (3)  What is the prevalence of hyperinsulinism in a general population of New York metropolitan area; (4) What are the patterns of progression and/or arrest of hyperinsulinism-to-T2D continuum; (5) What are the non-metabolic developmental, differentiative, immune-inflammatory, degenerative, and metabolic effects of undetected incremental degrees of insulin dysfunction; (6) How do the diagnostic efficiencies for T2D of post-glucose challenge and insulin responses compare with those of the standard glucose tolerance; (7) How does insulin-based hyperinsulinism modification and T2D reversal plan compare with those based on glycemic criteria, especially in the cases of gestational diabetes and large-sized babies; and (8) What might be the crucial clinical entities in which unmasked hyperinsulinism poses special hazards, i.e., autism, Asperger’s syndrome, pediatric dysautonomia, childhood weight gain and obesity, pediatric fatty liver, peripheral neuropathy,  drug-induced tissue repair responses (during chemotherapy for cancer, for instance), polycystic ovarian syndrome, pustular  acne, and diverse allergic and chronic immune-inflammatory disorders.

Insulin Dysregulation in Chronic Cellular Repair Responses

All repair mechanisms in the body have  expanded energy requirement demands. Insulin can be rightfully considered the master energy hormone of the body. From an evolutionary energetic perspective, the lowest blood insulin concentrations accompanied by unimpaired glucose tolerance have been designated optimal insulin homeostasis  (Table 1).  Table 2 showing the correlation of incremental glycemic changes sheds light on the hyperinsulinism-T2D continuum. Our article entitled “Shifting Focus From Glycemic Status to Insulin Homeostasis is posted in full at www.alidiabetes.org, and furnishes a large body of original observations, including many of the above-cited forms of toxicity of hyperinsulinism fully referenced.

Table 1. Insulin Homeostasis Categories in 506 Study Subjects Without Type 2 Diabetes
Insulin Category* Percentage of Subgroup Mean Peak Glucose  mg/dL(mmol/mL) Mean Peak Insulin (uIU/mL)
Exceptional Insulin Homeostasis    N =  12** 1.7% 110.2     (6.12) 14.3
Optimal Insulin Homeostasis            N =  126 24.9 % 121.2     (6.73) 26.7
Hyperinsulinism, Mild                         N =  197 38.9 % 136.5   (7.58) 58.5
Hyperinsulinism,  Moderate              N =  134 26.5 % 147.0    (8.16) 109.1
Hyperinsulinism,  Severe                   N =  49 9.7 % 150.0    (8.33) 231.0
#   Correlation coefficient, r value, for means of peak glucose and insulin levels in the five insulin categories is 0.84.

*Criteria for classification: (1) Exceptional insulin homeostasis, a subgroup of optimal insulin homeostasis with fasting insulin concentration of <2 uIU/mL and mean peak insulin concentration of <20; (2) optimal insulin homeostasis, peak insulin <40 accompanied by unimpaired glucose tolerance; (3) mild

Table 2. Insulin Homeostasis Categories in 178 Study Subjects With Type 2 Diabetes
Insulin Category Percentage of Subgroup Mean Peak Glucose mg/dL(mmol/mL) Mean Peak Insulin (uIU/mL)
T2D With Hyperinsulinism, Mild          N =  53 29.0% 252.0   (14.00) 55.4
T2D With Hyperinsulinism, Moderate N =  42   24.0% 242.1   (13.45) 112.4
T2D With Hyperinsulinism, Severe       N =  24 13.9% 224.6   (12.47) 298.0
T2DF With Low Insulin Levels               N =  59 33.1% 294.0    (16.33) 22.9

Reading Insulin/Glucose Profiles As Examining Surgical Pathology Slides

Within some months of beginning my study of insulin homeostasis with 3-hour post-glucose-challenge insulin and glucose profiles, I found myself reading the profiles as I read microscopic slides as a hospital surgical pathologist. One might expect that individual subjects will display wide variations in their insulin and glucose profiles in most instances. This, indeed, is the case . This point is amply demonstrated in case studies shown in Tables 3-7. Table 3 shows what is usually dismissed as an error of omitting the glucose challenge by the patient or the  lab staff since the “flat” post-glucose-challenge tolerance pattern is not a generally recognized entity. It is caused by a brisk initial insulin spike which masks the expected initial glucose spike. This can be readily proved by taking measurements at 1/2-hour post-challenge blood sample. Tables 7 documents insulin dysregulation in autism and pediatric dysautonomia.

Table 3. Optimal Insulin Homeostasis With Very Low Blood Insulin Concentrations and Unimpaired “Flat” Glucose Tolerance Curve* of A 52-Yr-Old 5’1” Woman With Constipation and Osteoarthritis.
Fasting 1-Hr 2-Hr 3-Hr
Insulin uIUi/mL <2 17 15 6
Glucose mg/mL 75 61 72 71

 

Table 4. Insulin and Glucose Profiles of 75-Yr-Old 5’7” Woman Weighing 192 lbs. Who Presented Following A Coronary Bypass Procedure With Fatigue, Sinusitis, and Without Known Type 2 Diabetes (Not An Uncommon Case In the Author’s Integrative Clinical Practice). A1c 5.6%.
6.3.2010 Fasting 1-Hr 2-Hr 3-Hr
Insulin uIUi/mL 9.8 25 92.4 2.2
 Glucose mg/mL 112 170 241 273
7.23.2013. Insulin Tests Not Ordered By Her Primary Physician. A1c 5.8%
Insulin uIUi/mL
Glucose mg/mL 97 159 219 247
5.11.2014. ”Mostly Good Compliance” By  Patient’s Account.  A1c  5.7
Insulin uIUi/mL 6.43 58.2 33.87 6.4
Glucose mg/mL 99 182 139 81
2016 Hospitalized for Angina. A1c 5.7. No Diabetic Drugs Prescribed By the Attendning Cardiologist.

 

Table 5. Reversal of Type 2 Diabetes in a 78-Yr-Old 5’2” Woman Weighing 162 Lbs. Achieved By Dramatic Hyperinsulinism Modification (Reduction of 3-Hr Insulin from 152 uIU/mL in 2013 to 75.2 in 2014 to 39.7 in 2015, indicating  restoration of Insulin Homeostasis.
4.30.2013 Fasting 1-Hr 2-Hr 3-Hr
Insulin uIUi/mL 16 59 113 152
 Glucose mg/mL 112 214 241 155
10.17.2014,   A1c  6.3%
Insulin uIUi/mL 23.8 36.9 114.7 75.2
 Glucose mg/mL 116 253 297 172
4.14.2015,  A1c 5.9%
Insulin uIUi/mL 6.2 42.9 51.2 39.7
 Glucose mg/mL 96 193 112 105

 

Table 6. Severe Hyperinsulinism In A Previously Health 13-Yr-Old Girl With Multiple Hospitalizations for Recurrent Pneumonia, Thrombocytopenia, Polyarthralgia, Polymyalgia , and Severe Optic Neuritis With Complete Loss of Vision in Right Eye. Her Final Diagnosis in the Hospital was Systemic Lupus Erythematosus*
Fasting 1Hr 2Hr 3Hr
Insulin uIU/mL 27.9 424.0 718.2 571.7
Glucose mg/mL 70 157 150 111
Insulin and Glucose Profiles Obtained After Four Months of Robust Integrative Parenteral Nutritional and Detox Therapies With Focus on Restoration of Gut Flora.
Insulin uIU/mL 7.2 238.5 208.0 132.0
Glucose mg/mL 81 181 130 97
*The patient showed dramatic improvement  in all areas except in right eye blindness. Follow-up questioning revealed a history of massive exposure to mold overgrowth while playing in an abandoned building.

Information Sources

I consider the journal Nature to be the supreme source of information in the world of science. Since 2015, Nature frequently e-published my comments expressing holistic-integrative perspective on health and healing concerning major articles published by the journal. Below are excerpts from five of those pieces on the subject of this proposal for APPNA (citations within the text are originals from e-publications):

  1. Shifting Focus From Glycemic Status to Insulin Homeostasis14

 Type 2 Diabetes (T2D) is rapidly eclipsing other chronic diseases in becoming the preeminent threat to human health worldwide…. The work of Yamaguchi and colleagues must be celebrated in this larger context. Their previous work involved generation of whole organs from donor pluripotent stem cells using their chimaera-forming ability to complement organogenesis-disabled host animals in vivo. They now report generation of autologous functional islets with interspecies organogenesis through interspecies blastocyst complementation. This stellar work advances the goal of treating diabetes with islet transplantation. Here, Yamaguchi  et al. also put forth a serious challenge to physician community: How to protect transplanted islet cells from the host elements that caused hyperinsulinism leading to Type 2 diabetes in the first place?

  1. Obesity, Energetics, Environment, and Hyperinsulinism23

Just how error-prone and self-correcting is science? Allison and colleagues raise a question that physicians often raise – in hospitals, clinics, and laboratories. A more compelling question for those interested in obesity, energetics, and inflammation, and insulin homeostasis is: How can the subjects of obesity and energetics be investigated and/or discussed without considering the tedious and disconcerting matter of environmental and inflammatory toxins that impair mitochondrial function and oxygen signaling? Automobile mechanics know well how their engines get clogged and lose efficiency and mileage. In 2004, the author published data concerning impaired mitochondrial function in chronic immune-inflammatory and metabolic disorders.1  His observations were validated by the work of others as well as his follow-up studies.23

  1. Osteocrin, Making Connections, and Autism16

Ataman et al. linked osteocrin, a gene expressed in muscles and bones, to a new primate-specific enhancer sequence that binds to a myocyte enhancer factor 2 (MEF2.) (ref. 1). MEF2C mutations resulting in haploinsufficiency represent a form of intellectual disability in humans. (ref.2,3). MEF2A- and MEF2C-binding sites are enriched in genes associated with idiopathic autism spectrum disorder (ref. 4).

This new osteocrin work is especially important for integrative clinicians who care for autism and other disorders of developmental neurobiology. No pharmacologic agents to treat autism spectrum are available at this time. However, it is well established that neuronal activity triggers distinct transcriptional responses in different neuronal subtypes (ref. 5) This offers an opening for integrative clinicians to investigate the potential benefits of non-pharmacologic approaches to enhance neuronal activity to evoke desirable neurological responses for improved clinical outcomes. Notable among these are dietary, nutritional, metabolic, and gut mircobiota-directed therapies, as well as educational and behavioral programs. Specifically, the use of injectable and oral glutathione, methylcobalamine, taurine, calcium, magnesium, vitamin B complex usually yield gratifying results in treating atism (ref. 6,7).

The work of Ataman et al inspires this writer to pursue his impeded progenitor cell progression model of autism (ref. 6). He put forth this unifying model as a frame of reference for establishing clinical priorities to improve clinical results by identifying and addressing all prenatal and postnatal challenges to developmental neurobiology which seem relevant to the pathogenesis of ASD. The core tenet of this model is impeded neuronal progenitor cell progression to mature neurons during antenatal and postnatal lives caused in autism is disrupted oxygen signaling (ref. 6,8,9) resulting from: (1) Krebs cycle dysfunction (ref. 10); (2) overdriven immune-inflammatory dynamics (ref. 11); and (3) disruptions of insulin homeostasis and IGF1-dynamics (ref. 12,13). The members of this trio amplify challenges to progenitor cell progression posed by one another, and impede progenitor cell progression during antenatal and postnatal lives.

  1. Insulin.Autism.Hypothalamus24

The work of Stanley et al. points out how their constructs targeting glucose-sensing neurons will also be applicable to other areas, including insulin signaling. I have two specific reasons for celebrating this work. First, my work with hyperinsulnism and diabetes led me to recognize a clear need for a shift of focus from glycemic status to insulin homeostasis for stemming the tide of Type 2 diabetes in children (ref. 2-4). Second, I have special interest in the subject of hyperinsulinism in children with neurological challenges, such as autism and dysautonomia. (ref.5) Readers might find the following data concerning four children with hyperinsulinism, two with autism and two with dysautonomina, interesting. The insulin and glucose profiles were obtained with blood samples drawn at fasting and 1-hour, 2-hour, and 3-hour after a 75-gram challenge. I also include an insulin profile of a healthy subject with unimpaired glucose tolerance as a control. Insulin and glucose concentrations in 3-hour insulin and glucose profiles of  four children given below are expressed in uIU/ml and mg/mL respectively.

Table 7. Insulin and Glucose Profiles of Two Children each With Autism, and Dysautonomia, and One Control Child .
Fasting 1-Hr 2-Hr 3-Hr
Autism Case 1
 Insulin uIU/mL 24.4 73.8 71.6 28
Glucose mg/mL 95 79 79 69
Autism Case  2
Insulin uIU/mL 6.2 40.3 41.5 24.8
Glucose mg/mL 96 131 109 57
Pediatric Dysautonomia Case 1
Insulin uIU/mL 9.3 90.7 119.9 53.8
Glucose mg/mL 78 165 141 99
Pediatric Dysautonomia Case 1
 Insulin uIUi/mL 3.9 49.59 13.1 7.8
Glucose mg/mL 84 96 71 77
Control Subject Without Any Neurologic Disorder
Insulin uIU/mL <2 18 4 <2
Glucose mg/mL 77 109 74 52

 

  1. Darwin Moms, Nursing Milk, and Antibiotic Resistance25

Darwin moms have much to teach clinicians like me. To cite one example, women in Punjab diligently follow the family tradition of mustard oil rubs over their bellies daily for forty days after delivering a baby. I recommend this simple remedy to my American patients who nearly always find it beneficial in improving bowel health and reducing abdominal fat. They also report good results with castor oil rubs for their colicky babies.

Darwin moms have taught me much about many other remedies for controlling pregnancy-related digestive-absorptive disruptions and for improving their nutritional,  metabolic, and immune status, as well as of their children. Such measures profoundly affect the nourishing quality and safety of nursing milk, a crucially important immune booster. This approach can be expected not only to reduce the need for antibiotics but also diminish the frequency and intensity of their adverse effects when antibiotics cannot be avoided.

APPNA and Global Challenges of Disrupted Oxygen and Insulin Signaling

In closing, APPNA has an impressive world-class “clinician capital.” What might it contribute to the daunting challenge of stemming global tides of diabetes? Hyperinsulinism is recognized not only as the primary pathogenetic  mechanism for Typ2 diabetes but also as playing central roles in  diverse developmental, diffferentiative,  immune-inflammatory,  cardiovascular, neurologic, hepatic, endocrine, and cellular repair-related pathologies. Within the broader evolutionary context, the incremental “non-metabolic effects” of disrupted insulin homeostasis inflict diffuse cellular injury in nearly all organ systems of the body. The case of a 13-yr-old with total loss of vision in one eye presented in Table 6 and those of children with autism and dysautonomia in Table 7 offer intellectual and clinical challenges worthy of APPNA physicians. The integrative clinical Protocol guidelines proposed here also harness myriad low-cost indigenous therapies. The oxygen-insulin dimensions of the Protocol provide the scientific underpinning and rationale for gauging and engaging therapeutic aspects of molecular biology of oxygen and insulin.

In this light, APPNA clinicians considering the Protocol may look forward to exploring rewarding new dimensions of the new global realities of health and healing. Excerpts from the writer’s comments published online by the journal Nature provide windows to some of these dimensions. I add here that I consider publications in Nature analogous to the U.S Supreme Court admitting cases – to be presented, argued for and against, and then to be ruled on.

References

  1. M. Respiratory-to-Fermentative (RTF) Shift in ATP Production in Chronic Energy Deficit States. Townsend Letter for Doctors and Patients. 2004;253:64-65.
  2. Chouchani ET, Victoria R. Pell VR, Edoardo Gaude E, et. al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014; 515:431–435.
  3. Ali M. Succinate Retention. In: Chouchani ET, Victoria R. Pell VR, Edoardo Gaude E, et. al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431–435. Data after references).
  4. Ali M. Oxygen and Aging. (Ist ed.) New York, Canary 21 Press. Aging Healthfully Book 2000.
  5. Ali M. Dysox Model of Diabetes and De-Diabetization Potential. Townsend Letter-The examiner of Alternative Medicine. 2007; 286:137-145.
  6. Ali M. Oxygen, Insulin Toxicity, Inflammation, And  the Clinical Benefits of Chelation. Part I. Townsend Letter-The examiner of Alternative Medicine. 2009;315:105-109. October, 2009.
  7. Ai M. Ali’s Plan for Reversing Diabetes. New York, Canary 21 Press. Aging Healthfully Book 2011.
  8. Ali M. Oxidative regression to primordial cellular ecology. J Integrative Medicine 1998; 2:4-55.
  9. Oxygen, Insulin Toxicity, Inflammation, and  the Clinical Benefits of Chelation. Part I. Townsend Letter-The examiner of Alternative Medicine. 2009;315:105-109. October, 2009.
  10. Ali M. Importance of Subtyping Diabetes Type 2 Into Diabetes Type 2A and Diabetes Type 2B. Townsend Letter-The Examiner of Alternative Medicine. 2014; 369:56-58.
  11. Ali M. Dasoju S, Karim N, Amin J, Chaudary D. Study of Responses to Carbohydrates and Non-carbohydrate Challenges In Insulin-Based Care of Metabolic Disorders. Townsend Letter-The Examiner of Alternative Medicine. 2016; 391:48-51.
  12. Ali M. Epidemic of Dysoxygenosis and the Metabolic Syndrome. In: The Principles and Practice of Integrative Medicine. Volume 5. Pp 246-256. Canary 21 Press. New York. 2005.
  13. Ali M. Ali Fayemi AO, Shifting Focus From Glycemic Statsu to Insulin Homeostasis. Ali M, Fayemi AO, Ali O, Dasoju S, Chaudhary D, Hameedi S, Amin J, Ali K, and Svoboda B. Shifting focus from glycemic status to insulin homeostasis for stemming global tides of hyperinsulinism and Type 2 diabetes. Townsend Letter – The examiner of Alternative Medicine. 2017;402:91-96.
  14. Ali M. Shifting Focus From Glycemic Status to Insulin Homeostasis. E-comments In Nature. 2017;542:191.Re: Kobayashi T, Yamaguchi T, Hamanaka S, et al. Generation of rat pancreas in mouse by interspecies blastocyt injection of pluripotent stem cells. Cell. 2010;142:787-799.
  15. Ali M. Ali M. Molecular basis of Autism and Dysautonomia. Townsend Letter – The examiner of Alternative Medicine . In Press.
  16. Ali M. Osteocrin, Making Connections, and Autism. 2016;539:242.
  17. Arcaro G, Cretti A, Balzano S, et al. Insulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms. Circulation. 2002;105:576-582.
  18. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist. The Journal of Pediatrics. 1999;135:162-168.
  19. Ali M. Cancer,-Endothelium Dynamics, and DR6-Based Anti-Metaststic Therapies. Comments e-published in: 2016;536:215-218.
  20. Ali M. Darwin, Oxygen Homeostasis, and  Oxystatic Therapies. Volume X, 3 rd. Edi The Principles and Practice of Integrative Medicine (2009) New York. Institute of Integrative Medicine Press.
  21. Ali M. The Principles and Practice of Integrative Medicine Volume  XI: 3rd. Edi. Darwin, Dysox, and Disease. 2000. 3rd. Edi. 2008. New York.  (2009) Institute of Integrative Medicine Press.
  22. Ali M. The Principles and Practice of Integrative Medicine Volume  XII: Darwin, Dysox, and Integrative Protocols. New York (2009). Institute of Integrative Medicine Press.
  23. Ali M. Obesity, Energetics, Environment, and Hyperinsulinism. e-comments. In: Nature. 2016;530:27.
  24. Ali M. Autism.Hypothalamus. e-published at www.Nature.com. In: Nature. 2016;531:647-650.
  25. Ali M. Darwin Moms , Nursing Milk, and Antibiotic Resistance. E-published at Nature.com. 533:212.

END Protocol

Why Is Diagnosis of Prediabetes a Blessing?

Majid Ali, M.D.

I recognize Three Blessings of the Diagnosis of Prediabetes


 

Three Blessings of the Diagnosis of Prediabetes

First, one does not have to be diabetic.

Second, the insulin toxicity of prediabetes is recognized and reversed.

Third, the results of treatment of all other health problems are improved.


 

3D Plan for Reversing Prediabetes

  1. Diet
  2. Detox
  3. Dysoxic Comorbidities

For more information, go to 3D Insulin Protocol at this site.


 

 

Oxidation Model of Diabetes Validated – 20 Years Later

Majid Ali, M.D.

I published my oxidative model of diabetes in 1995. It was fully validated By Canadian Journal of Diabetes in 2015.


 

In my book RDA – Rats, Drugs, and Assumptions  (1995), on pages 277-280 I presented my oxidative theories of diabetes and Alzheimer’s disease. My purpose in presenting my oxidative theory of Type 2 diabetes (T2D) and Alzheimer’s disease (AD) together was to challenge the then-prevailing notions that T2D is caused by inappropriate secretion and functions of a pancreatic hormone amylin, as well as deposits of amyline protein in the pancreas and Alzheimer’s disease is caused by deposits of amyloid protein in the brain. My basic argument then was that both amylin and amyloid proteins are deposited as a result of oxidative damage to tissues and cannot be considered as root causes of T2D and AD.


Title and Abstract of the Article inCanadian Journal of Diabetes
Aouacheri  Q, Saka S, Krim M, et al. The Investigation of the Oxidative Stress-Related Parameters in Type 2 Diabetes Mellitus. 2015;39:44-49.
Abstract
Introduction
analysisResultsDiscussionConclusionAcknowledgementsAuthor DisclosuresReferences
Objective
Oxidative stress, defined as an imbalance between reactive oxygen species production and breakdown by endogenous antioxidants, is closely associated with diabetes mellitus. The diabetes is characterized by hyperglycemia together with biochemical alterations of glucose and lipid peroxidation. Oxidative stress has been implicated in the pathogenesis of type 2 diabetes and its complications.
Methods
This study was conducted to investigate the variation in oxidative stress-related parameters in type 2 diabetes. Blood serum samples were collected from diabetes patients and nondiabetes healthy controls. Glucose concentrations, levels of glycated hemoglobin (A1C) and serum oxidative stress markers (glucose-6-phosphate dehydrogenase [G6PDH], malondialdehyde [MDA], glutathione [GSH], glutathione reductase [GR], glutathione peroxidase [GPx] and superoxide dismutase [SOD]) were estimated.
Results
Fasting serum glucose concentration in type 2 diabetes patients of both sexes was increased significantly as compared with the healthy controls. Level of A1C was greater than standards. Significant elevation in MDA level and depletion in GSH content were observed in diabetes patients in comparison with controls. The diminution in G6PDH activity was accompanied in part by a decrease in the antioxidative enzymes activities (GPx and GR), and in part by an increase in SOD activity in all diabetes patients as compared with the control group. The regression analysis showed no correlation between diabetes duration and severity of oxidative stress; however, there was a significant association between A1C and severity of oxidative stress.
Conclusions
The present study shows that there is an oxidative stress state in type 2 diabetes patients compared with healthy subjects. Our data suggest that chronic hyperglycemia causes a significant change in oxidative stress markers.

Dr. Ali’s Library of Articles and Videos on Diabetes

Reversing Diabetes by Regenerating Pancreas | Majid Ali MD | The Ali …

Jul 18, 2014 – Majid Ali, M.D. An Illustrative Case Study Doctors have recently … Typically, the peak bloodinsulin levels in pre-diabetes are five to ten times or …

Dr. Ali’s Diabetes Plan – Understanding Diabetes | The Ali Academy …

Oct 31, 2014 – Dr. Ali’s Breakfast I consider an optimal breakfast to be the first essential in any … Majid Ali MD … I am not a diabetic; however, I find it to be most valuable for individuals with insulin resistance, pre-diabetes, and diabetes.

Dr. Ali’s Insulin Reduction Protocol

Dr. Ali’s Insulin Reduction Protocol. For Improving Insulin Efficiency. Majid Ali, M.D.. To reverse pre-diabetes and diabetes (completely or partially), my primary …

Ali Diabetes | Preventing and Reversing Diabetes With Insulin Literacy

Shifting Focus From Glycemic Status to Insulin Homeostasis for Stemming Global Tides of Hyperinsulinism and Type 2 Diabetes by Majid Ali, MD, FRCS (Eng), …

Insulin Homeostasis | Ali Diabetes

Apr 18, 2017 – Aug 4, 2012 – The Oxygen Model of Insulin Toxicity – Majid Ali, M.D. … in my book “Dr. Ali’s Plan for Reversing Diabetes,” I presented the …

Majid Ali, M.D. * Insulin Toxicity De-mystifies the Metabolic Syndrome …

Jun 28, 2012 – Uploaded by majid ali

The true mature of the metabolic syndrome is insulin toxicity. The term … Majid Ali, M.D. * Insulin Toxicity …

Reversing Diabetes – Majid Ali – AliAcademy.org

aliacademy.org/reversing_diabetes.htm

In this 40-minute seminar, Professor Majid Ali, M.D. Presents his reasons for why … Simply stated,diabetes Type 2A is a state of insulin toxicity created by insulin …

Dr. Ali’s Diabetes Reversal program – Dr. Ali’s Virtual Medical Library

drali1.org/dr__ali’s_diabetes_reversal_guidelines.htm

Dr. Ali’s Diabetes Reversal Guidelines. Majid Ali, M.D.. The science and philosophy of reversing diabetesType 2 associated with excess insulin is simple to …

S even Stages of Insulin Toxicity – Dr. Ali’s Virtual Medical Library

drali1.org/insulin_seven_stages.htm

Majid Ali, M.D … The fifth stage of insulin toxicity is Type 2 diabetes with the use of diabetes drugs … k Two Ways of Losing DiabetesInsulin Up, Insulin Down.


Dr. Ali’s Breakfast for Losing Weight, Reversing Diabetes, and Staying …

Aug 28, 2014 – Majid Ali, M.D.A Breakfast for Insulin-Smart Eating and Healthful Aging There is never a valid reason for missing breakfast. So strong is my …

Dr. Ali’s Course on Insulin Toxicity | – alihealing.org

Jan 11, 2017 – Majid Ali, M.D. Workable Simplicity to Understand Maddening Complexity of Three Scourges of Our Time Dr. Ali’s InsulinDiabetes Video and …

Insulin-Based Diabetes Reversal Plan | Ali Academy

Oct 26, 2014 – Posts about Insulin-Based Diabetes Reversal Plan written by Majid Ali MD.

Dysox Model of Diabetes and De-Diabetization Potential (May 2007 …

by Majid Ali, MD … Is diabetes an insulin problem? … In type 1 diabetes, insulin itself becomes a potent autoantigen and initiates autoimmune injury to pancreatic …

Diabetes and insulin Majid Ali MD on Vimeo

https://vimeo.com › Majid Ali › Videos

Diabetes and insulin Majid Ali MD. from Majid AliPRO 2 years ago. Follow. Download Share . Loading. Vimeo. About Vimeo · Vimeo Blog · Vimeo Guidelines …

Diabetes Reversal With Insulin Profiling Majid Ali MD on Vimeo

https://vimeo.com › Majid Ali › Videos
Mar 24, 2014

Professor Majid Ali shares information about “Majid Ali, M.D. * Diabetes Reversal With Insulin Profiling “

Insulin Toxicity | Childrens Health Corps

Jul 15, 2014 – Insulin-Wise Eating Majid Ali, M.D. To reverse pre-diabetes and diabetes (completely or partially), my primary objective is to lower both blood …

Dr. Ali’s Insulin Course — Blogs, Pictures, and more on WordPress

av.wordpress.com/tag/dr-alis-insulin-course/

Diabetes Insulin Videos. Majid Ali, M.D.. Links to Videos on Prevent and Reverse Diabetes. What isDiabetes. What Is Insulin? What Are Its Functions?

Reporting a comment for the article : Bidirectional electromagnetic …

http://www.nature.com › Journal home › Archive › Authors

Mar 31, 2016 – Majid Ali said: Hypothalamic Influences on Metabolism, Feeding, and InsulinHomeostasis. The report of Stanley et al (ref. … Ali M. Dysox Model of Model of Diabetes and De-Diabetization Potential. Townsend Letter-The …